Literature DB >> 31009043

Metformin in 2019.

James Flory1, Kasia Lipska2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31009043     DOI: 10.1001/jama.2019.3805

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  67 in total

1.  Characterization of on-target adverse events caused by TRK inhibitor therapy.

Authors:  D Liu; J Flory; A Lin; M Offin; C J Falcon; Y R Murciano-Goroff; E Rosen; R Guo; E Basu; B T Li; J J Harding; G Iyer; K Jhaveri; M M Gounder; N N Shukla; S S Roberts; J Glade-Bender; L Kaplanis; A Schram; D M Hyman; A Drilon
Journal:  Ann Oncol       Date:  2020-05-15       Impact factor: 32.976

Review 2.  Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases.

Authors:  Tian Li; Rui Providencia; Wenhua Jiang; Manling Liu; Lu Yu; Chunhu Gu; Alex Chia Yu Chang; Heng Ma
Journal:  Drugs       Date:  2022-01-15       Impact factor: 9.546

3.  Increasing Psychiatrists' Role in Addressing the Cardiovascular Health of Patients With Severe Mental Illness.

Authors:  Martha Ward
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

4.  Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.

Authors:  Katherine M Reitz; Oscar C Marroquin; Mazen S Zenati; Jason Kennedy; Mary Korytkowski; Edith Tzeng; Stephen Koscum; David Newhouse; Ricardo Martinez Garcia; Jennifer Vates; Timothy R Billiar; Brian S Zuckerbraun; Richard L Simmons; Stephen Shapiro; Christopher W Seymour; Derek C Angus; Matthew R Rosengart; Matthew D Neal
Journal:  JAMA Surg       Date:  2020-06-17       Impact factor: 14.766

Review 5.  [Treatment of diabetes mellitus in perioperative medicine-an update].

Authors:  B Rupprecht; A Stöckl; S Stöckl; C Dietrich
Journal:  Anaesthesist       Date:  2020-11-03       Impact factor: 1.041

6.  Baseline Characteristics and Patient-Reported Outcomes of ADPKD Patients in the Multicenter TAME-PKD Clinical Trial.

Authors:  Stephen L Seliger; Terry Watnick; Andrew D Althouse; Ronald D Perrone; Kaleab Z Abebe; Kenneth R Hallows; Dana C Miskulin; Kyongtae T Bae
Journal:  Kidney360       Date:  2020-12-31

Review 7.  Use of Anti-Diabetic Agents in Non-Diabetic Kidney Disease: From Bench to Bedside.

Authors:  Sungjin Chung; Gheun-Ho Kim
Journal:  Life (Basel)       Date:  2021-04-25

Review 8.  Controversies in Gestational Diabetes.

Authors:  Chloe A Zera; Ellen W Seely
Journal:  touchREV Endocrinol       Date:  2021-08-04

Review 9.  Novel Approaches to Restore Pancreatic Beta-Cell Mass and Function.

Authors:  Alena Welters; Eckhard Lammert
Journal:  Handb Exp Pharmacol       Date:  2022

10.  AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism.

Authors:  Flavio R Palma; Bianca A Ratti; Veronica Paviani; Diego R Coelho; Rodrigo Miguel; Jeanne M Danes; Sofia V Zaichik; Andre L de Abreu; Sueli O Silva; Yiliang Chen; Roy L Silverstein; Uppal Karan; Dean P Jones; Marcelo G Bonini
Journal:  Oncogene       Date:  2021-07-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.